Bioidentical hormones, menopausal women, and the lure of the "natural" in U.S. anti-aging medicine

Social Science and Medicine

Volumn 132, Issue , 2015, Pages 79-87

  Fishman, Jennifer R ^a   Flatt, Michael A ^b   Settersten, Richard A ^c  

^a MCGILL UNIVERSITY   (Canada)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OREGON STATE UNIVERSITY   (United States)

Author keywords

Aging; Anti aging; Bioidentical hormones; Biomedicine; Hormone replacement therapy; Menopause; United States; Women's health

Indexed keywords

ESTRADIOL; ESTRIOL; ESTRONE; HERBACEOUS AGENT; PRASTERONE; PROGESTERONE; TESTOSTERONE; BIOLOGICAL PRODUCT;

AGING; DRUG DEVELOPMENT; DRUG PRESCRIBING; HORMONE; WOMENS HEALTH;

ADULT; AGED; AGING; ALTERNATIVE MEDICINE; ARTICLE; ATTITUDE TO AGING; BIOIDENTICAL HORMONE REPLACEMENT THERAPY; BIOMEDICINE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CREAM; DRUG PELLET; FEMALE; HEALTH CARE PERSONNEL; HORMONE SUBSTITUTION; HUMAN; MALE; MENOPAUSAL SYNDROME; PATIENT ATTITUDE; PHYSICIAN ATTITUDE; PILL; PRESCRIPTION; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SELF REPORT; TRANSDERMAL PATCH; TREATMENT INDICATION; UNITED STATES; WOMEN'S HEALTH; ATTITUDE TO HEALTH; ESTROGEN THERAPY; INTERVIEW; MENOPAUSE; PHYSIOLOGY; PROCEDURES; PSYCHOLOGY;

AGING; ATTITUDE TO HEALTH; BIOLOGICAL PRODUCTS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MENOPAUSE; UNITED STATES; WOMEN'S HEALTH;

EID: 84925018030     PISSN: 02779536     EISSN: 18735347     Source Type: Journal    
DOI: 10.1016/j.socscimed.2015.02.027     Document Type: Article

References (74)

1. A4M Bioidentical Hormone Replacement Therapy in the Anti-aging Clinical Setting: An Official Position Statement 2006, Retrieved from, (accessed 01.05.14.). http://www.worldhealth.net/news/bioidentical_hormone_replacement_therapy/.
2. ACOG Compounded Bioidentical Menopausal Hormone Therapy. Number 532 2012, Retrieved from, (accessed 28.10.14.). http://www.acog.org/-/media/Committee-Opinions/Committee-on-Gynecologic-Practice/co532.pdf?dmc=1%26ts=20141029T1534115774.
3. Baer H.A. Toward an Integrative Medicine: Merging Alternative Medicine with Biomedicine 2004, Altamira Press, Walnut Creek.
4. Baer H.A., Coulter I. Introduction-Taking stock of integrative medicine: broadening biomedicine or co-optation of complementary and alternative medicine?. Health Sociol. Rev. 2008, 17(4):331-341.
5. Balsamo A. Technologies of the Gendered Body: Reading Cyborg Women 1996, Duke University Press, Durham.
6. Beck U. Risk Society: Towards a New Modernity 1992, Sage Publications, London.
7. Bell S.E. Changing ideas: the medicalization of menopause. Soc. Sci. Med. 1987, 24(6):535-542.
8. Bhattacharya S. Up to 140,000 Heart Attacks Linked to Vioxx. New Scientist 2005, January, Retrieved from, (accessed 01.05.14.). http://www.newscientist.com/article/dn6918-up-to-140000-heart-attacks-linked-to-vioxx.html#.U2P0HIFdWW-.
9. The Social Construction of Technological Systems: New Directions in the Sociology and History of Technology 1987, MIT Press, Cambridge. W.E. Bijker, T.P. Hughes, T.J. Pinch (Eds.).
10. Shaping Technology/building Society: Studies in Sociotechnical Change 1994, MIT Press, Cambridge, MA. E. Bijker Wiebe, J. Law (Eds.).
11. Bond M., Bywaters P. Working it out for ourselves: women learning about hormone replacement therapy. Women's Stud. Int. Forum 1998, 21(1):65-76.
12. Boothby L.A., Doering P.L. Bioidentical hormone therapy: a panacea that lacks supportive evidence. Curr. Opin. Obstetrics Gynecol. 2008, 20(4):400-407.
13. Bowen G.A. Grounded theory and sensitizing concepts. Int. J. Qual. Methods 2006, 5(3):12-23.
14. Braidotti R. The Posthuman 2013, Polity Press, Cambridge.
15. Buring J.E., Bain C.J., Ehrmann R.L. Conjugated estrogen use and risk of endometrial cancer. Am. J. Epidemiol. 1986, 124(3):434-441.
16. Calasanti T.M., King N. Firming the floppy penis: age, class, and gender relations in the lives of old men,Men and Masculinities 2005, 8(1):3-23.
17. Carpenter D., Tobbell D.A. Bioequivalence: the regulatory career of the pharmaceutical concept. Bull. Hist. Med. 2011, 85(1):93-131.
18. Synthetic Planet: Chemical Politics and the Hazards of Modern Life 2003, Routledge, New York. M.J. Casper (Ed.).
19. Chlebowski R.T., Prentice R.L., Stefanick M.L., Manson J.E., Gass M., Aragaki A.K., et al. Breast cancer after use of estrogen plus progestin in postmenopausal women. N.Engl. J. Med. 2009, 360:573-587.
20. Cirigliano M. Bioidentical hormone therapy: a review of the evidence. J.Women's Health 2007, 16:600-631.
21. Col N.F., Eckman M.H., Karas R.H., Pauker S.G., Goldberg R.J., Ross E.M., et al. Patient-specific decisions about hormone replacement therapy in postmenopausal women. JAMA 1997, 277(14):1140-1147.
22. Ehrenreich B., English D. For Her Own Good: 150 Years of the Experts' Advice to Women 1989, Anchor Books, New York.
23. Ettinger B., Grady D., Tosteson A.N., Pressman A., Macer J.L. Effect of the women's health initiative on women's decisions to discontinue postmenopausal hormone therapy. Obstetrics Gynecol. 2003, 102(6):1225-1232.
24. FDA Bio-identicals: Sorting Myths from Facts 2008, Retrieved from. http://www.fda.gov/forconsumers/consumerupdates/ucm049311.htm.
25. Fishman J.R., Mamo L. What's in a disorder: a cultural analysis of the medical and pharmaceutical constructions of male and female sexual dysfunction. Women Ther. 2002, 24(2):179-193.
26. Fishman J.R., Settersten R.A., Flatt M.A. In the vanguard of biomedicine? the curious and contradictory case of anti-ageing medicine. Sociol. Health Illn. 2010, 32(2):197-210.
27. Flatt M.A., Settersten R.A., Ponsaran R., Fishman J.R. Are "anti-aging medicine" and "successful aging" two sides of the same coin? views of anti-aging practitioners. J.Gerontology: Soc. Sci. 2013, 68(6):944-955.
28. Fugh-Berman A., Bythrow J. Bioidentical hormones for menopausal hormone therapy: variation on a theme. J.general Intern. Med. 2007, 22:1030-1034.
29. Glaser B.G., Strauss A.L. The Discovery of Grounded Theory: Strategies for Qualitative Research 1967, Aldine, Chicago.
30. Goldstein M.S. Alternative Health Care: Medicine, Miracle or Mirage? 1999, Temple University Press, Philadelphia.
31. Greene J.A. Generic: The Unbranding of Modern Medicine 2014, Johns Hopkins University Press, Baltimore.
32. Griffiths F. Women's control and choice regarding HRT. Soc. Sci. Med. 1999, 49:469-481.
33. Posthuman Bodies 1995, Indiana University Press. J.M. Halberstam, I. Livingston (Eds.).
34. Haraway D. Simians, Cyborgs and Women: The Reinvention of Nature 1991, Routledge, New York.
35. Hayles N.K. How We Became Posthuman: Virtual Bodies in Cybernetics, Literature, and Informatics 1999, University of Chicago Press, Chicago.
36. Heiss G., Wallace R., Anderson G.L., Aragaki A., Beresford S.A., Brzyski R., et al. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA 2008, 299(9):1036-1045.
37. Hersh A.L., Stefanick M.L., Stafford R.S. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 2004, 291(1):47-53.
38. Hunter M.S., O'Dea I., Britten N. Decision-making and hormone replacement therapy: a qualitative analysis. Soc. Sci. Med. 1997, 45(10):1541-1548.
39. Jones J.B. Hormone replacement therapy: women's decision-making processes. Soc. Work Health Care 1999, 28(3):95-111.
40. Joyce K., Loe M. Technogenarians: Studying Health and Illness through an Ageing, Science, and Technology Lens 2010, Wiley-Blackwell, Oxford.
41. Joyce K., Mamo L. Graying the cyborg: new directions in feminist analyses of aging, science, and technology. Age Matters: Realigning Feminist Thinking 2006, 99-121. Routledge, New York. T. Calasanti, K. Slevin (Eds.).
42. Juengst E.T. Annotating the moral map of enhancement: gene doping, the limits of medicine, and the spirit of sport. Performance-enhancing Technologies in Sports: Ethical, Conceptual, and Scientific Issues 2009, 175-200. Johns Hopkins University Press, Baltimore. T.H. Murray, K.J. Maschke, A.A. Wasunna (Eds.).
43. Kaufert P.A., Gilbert P. Women, menopause, and medicalization. Cult. Med. Psychiatry 1986, 10(1):7-21.
44. Kelner M., Welman B. Health care and consumer choice: medical and alternative therapies. Soc. Sci. Med. 1997, 45(2):203-212.
45. Kennedy D.L., Baum C., Forbes M.B. Noncontraceptive estrogens and progestins: use patterns over time. Obstetrics Gynecol. 1985, 65(3):441-446.
46. Kreatsoulas C., Anand S.S. Menopausal hormone therapy for the primary prevention of chronic conditions. Pol. Arch. Med. Wewn. 2013, 123(3):112-117.
47. Krieger N., Löwy I., Aronowitz R., Bigby J., Dickersin K., Garner E., et al. Hormone replacement therapy, cancer, controversies, and women's health: historical, epidemiological, biological, clinical, and advocacy perspectives. J.Epidemiol. Community Health 2005, 59(9):740-748.
48. Lamb G.M. ANew Corporate Villain - Drugmakers? Christian Science Monitor 2004, September 20, Retrieved from, (accessed 01.05.14.). http://www.csmonitor.com/2004/0920/p11s02-ussc.html.
49. Lancet editorial HRT: what are women (and their doctors) to do?. Lancet 2004, 364(9451):2069-2070.
50. Latour B. We Have Never Been Modern, (C. Porter, trans.) 1993, Harvard University Press, Cambridge.
51. Leng K.W. On menopause and cyborgs: or, towards a feminist cyborg politics of menopause. Body Soc. 1996, 2(3):33-52.
52. Lupton D. Constructing the menopausal body: the discourses on hormone replacement therapy. Body Soc. 1996, 2(1):91-97.
53. Lynch N., Berry D. Differences in perceived risks and benefits of herbal, over-the-counter conventional, and prescribed conventional, medicines, and the implications of this for the safe and effective use of herbal products. Complement. Ther. Med. 2007, 15(2):84-91.
54. Mamo L., Fishman J.R. Potency in all the right places: viagra as a gendered technology of the body. Body Soc. 2001, 7(4):13-35.
55. Mamo L., Fosket J.R. Scripting the body: pharmaceuticals and the (re)making of menstruation. Signs: J. Women Cult. Soc. 2009, 34(3):925-950.
56. Marshall B. Science, medicine and virility surveillance: 'sexy seniors' in the pharmaceutical imagination. Sociol. Health Illn. 2010, 32(2):211-224.
57. Miles M.B., Huberman M. Qualitative Data Analysis: An Expanded Sourcebook 1994, Sage Publications, Inc, Thousand Oaks.
58. Moore L.J. 'It's like you use pots and pans to cook. It's the tool': the technologies of safer sex. Sci. Technol. Hum. Values 1997, 22(4):434-471.
59. Mykytyn C.E. Anti-aging medicine: a patient/practitioner movement to redefine aging. Soc. Sci. & Med. 2006, 62(3):643-653.
60. News M.D. Compounding Pharmacies Benefit Patients and Physicians 2010, July 1, Retrieved from, (accessed 01.05.14.). http://www.mdnews.com/news/2010_07/05867_julaug10_compounding-pharmacies-benefit-patients-and-physicians-.aspx.
61. NIH Osteoporosis. NIH Consensus Statement Online 1984, April 2-4, 5(3):1-6. Retrieved from, (accessed 01.05.14.). http://consensus.nih.gov/1984/1984Osteoporosis043html.htm.
62. Ortner S.B. Is female to male as nature is to culture?. Fem. Stud. 1974, 1(2):5-31.
63. Oudshoorn N. Beyond the Natural Body: An Archaeology of Sex Hormones 1994, Routledge, New York.
64. Oudshoorn N.E.J. Menopause, only for women? the social construction of menopause as an exclusively female condition. J.Psychosom. Obstet. Gynecol. 1997, 18(2):137-144.
65. PCCA What Is Compounding? 2014, n.d., Retrieved from, (accessed 01.05.14.). http://www.pccarx.com/what-is-compounding.
66. Schneirov M., Geczik J.D. ADiagnosis for Our Times: Alternative Health, from Lifeworld to Politics 2003, State University of New York, Albany.
67. Seaman B., Seaman G. Women and the Crisis in Sex Hormones 1977, Bantam, New York.
68. Strauss A., Corbin J. Basics of Qualitative Research: Techniques and Procedures for Developing Grounded Theory 1998, Sage, Thousand Oaks.
69. Watkins E.S. The Estrogen Elixir: A History of Hormone Replacement Therapy in America. Baltimore 2007, The Johns Hopkins University Press.
70. Watkins E.S. 'Educate yourself': consumer information about menopause and hormone replacement therapy. Medicating Modern America: Prescription Drugs in History 2007, 97-130. New York University Press, New York. A. Tone, E.S. Watkins (Eds.).
71. Wilson R.A. Feminine Forever 1966, M Evans Company, New York, NY.
72. Winner L. Do artifacts have politics?. Daedalus 1980, 109(1):121-136.
73. Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's health initiative randomized controlled trial. JAMA 2002, 288(3):321-333.
74. Zuckerman M., Weintraub B., Martin C., Hoggatt J. The Hormone Replacement Therapy Market for the Treatment of Menopausal Symptoms in the U.S.: A Model of 1998-2021 Revenue and Patients Treated. A Report by InThought Research, a Division of Symphony Health Solutions 2013, (accessed 01.11.14.). http://www.therapeuticsmd.com/Images/Symphony.pdf.